Form 4: AbCellera Biologics CEO Exercises Stock Options, Disposes of Shares
SEC Form 4 Filing
AbCellera Biologics CEO Carl L. G. Hansen exercised stock options and disposed of 56,125 common shares on February 26, 2024.
Summary
- On February 26, 2024, Carl L. G. Hansen, CEO of AbCellera Biologics Inc., exercised options to acquire 56,125 common shares at a price of $2.7 per share.
- Following the exercise of these options, Mr. Hansen disposed of 56,125 common shares.
- After the transaction, Mr. Hansen directly owns 8,428,598 derivative securities and 729,625 common shares.
- He also indirectly owns 55,802,493 common shares through Thermopylae Holdings Ltd., an entity wholly owned by him.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard Form 4 filing detailing stock option exercise and share disposal. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing reflects insider transactions, which are closely monitored by investors for insights into management's perspective on the company's value and future prospects. Option exercises and share disposals are common for executives and can be part of their compensation packages or personal financial planning.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership, but it's unlikely to be significant given the relatively small number of shares involved compared to the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 11/18/2021 | First tranche of options vested. |
| 02/26/2024 | Transaction date: Exercise of stock options and disposal of shares. |
| 02/27/2024 | Date of Form 4 signature. |
| 11/27/2030 | Expiration date of share options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.